Extended Data Fig. 8. Multiplex immunohistochemistry staining optimization for CD3, CD4, CD8, CD19, CD20, CD138, IgA, IgG, pIgR and PCK in glioblastoma tissues, and for pIgR in kidney tissues.
a, b, Multiplex staining of glioblastoma tissue sections (n = 5) with anti-human CD3, CD4, CD8, CD19, CD20 and CD138 antibodies (a), and IgA, IgG, pIgR and PCK antibodies (b). Scale bar, 100 μm. c, Multiplex staining of healthy kidney tissue sections (n = 4) with anti-human pIgR antibody and respective isotype control. Scale bar, 100 μm.